You are here
- Home
- Therapy Areas
- Oncology/Infection
A randomised, double blinded, multicentre phase II study to assess the efficacy of olaparib (AZD2281, KU-0059436) in combination with paclitaxel
- Disease
- gastric cancer
- Drug Name
- Olaparib
- Generic Name
- Olaparib (AZD2281)
- Sponsor
- AstraZeneca
- Drug Status
- In Development
- Phase
- II
- Start Date
- Feb 2, 2010
- Study Name
- D0810C00039
- Study Id
- D0810C00039
- ClinicalTrials.gov ID
- NCT01063517
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
